Docosahexaenoic acid-phosphatidylcholine improves cognitive deficits in an Aβ23-35-induced Alzheimer’s disease rat model

Current Topics in Medicinal Chemistry

Volumn 16, Issue 5, 2016, Pages 558-564

  Qu, Mei Hua ^a   Yang, Xiaoyun ^a   Wang, Yuming ^b   Tang, Qingjuan ^b   Han, Hailin ^a   Wang, Jia ^a   Wang, Guo Du ^c   Xue, Changhu ^b   Gao, Zhiqin ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

AD rats; Cognitive improvement; DHA PC; GSH Px; SOD; Tau phosphorylation

Indexed keywords

DOCOSAHEXAENOIC ACID PHOSPHATIDYLCHOLINE COMPLEX; GLUTATHIONE PEROXIDASE; PHOSPHATIDYLCHOLINE; SUPEROXIDE DISMUTASE; TAU PROTEIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); DOCOSAHEXAENOIC ACID; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOID BETA PROTEIN[25-35] INDUCED ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL STRUCTURE; CEPHALOPOD; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPAL CA1 REGION; LATENT PERIOD; MALE; MORRIS WATER MAZE TEST; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STHENOTEUTHIS OUALANIENSIS; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; COGNITION DISORDERS; COMPLICATION; DECAPODIFORMES; DISEASE MODEL; ISOLATION AND PURIFICATION; METABOLISM; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION DISORDERS; DECAPODIFORMES; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; FEMALE; MALE; PEPTIDE FRAGMENTS; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR;

EID: 84973424009     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150813144437     Document Type: Article

References (32)

1. Dubois, B.; Feldman, H.H.; Jacova, C.; Cummings, J.L.; Dekosky, S.T.; Barberger-Gateau, P.; Delacourte A.; Frisoni, G.; Fox, N.C.; Galasko, D.; Gauthier S.; Hampel, H.; Jicha, G.A.; Meguro K.; O'Brien, J.; Pasquier, F.; Robert, P.; Rossor, M.; Salloway, S.; Sarazin, M.; de Souza, L.C.; Stern, Y.; Visser, P.J.; Scheltens, P. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol., 2010, 9, 1118-1127.
2. Hashimoto, M.; Hossain, S.; Shimada, T.; Sugioka, K.; Yamasaki, H.; Fujii, Y.; Ishibashi, Y.; Oka, J.; Shido, O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem., 2002, 81(5), 1084-91.
3. Schaefer, E.J.; Bongard, V.; Beiser, A.S.; Lamon-Fava, S.; Robins, S.J.; Au, R.; Tucker, K.L.; Kyle, D.J.; Wilson, P.W.; Wolf, P.A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol., 2006, 63(11), 1545-1550.
4. Janssen, C.I.; Kiliaan, A.J. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog. Lipid Res., 2014, 53, 1-17.
5. Cunnane, S.C.; Chouinard-Watkins, R.; Castellano, C.A.; Barberger-Gateau, P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids, 2013, 88(1), 61-70.
6. Cederholm, T.; Salem Jr N.; Palmblad, J. Omega-3 fatty acids in the prevention of cognitive decline in humans, Adv. Nutr., 2013, 4(6), 672-676.
7. Beydoun, M.A.; Kaufman, J.S.; Satia, J.A.; Rosamond, W.; Folsom, A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the atheroscleros is risk in communities study. Am. J. Clin. Nutr., 2007, 85(4), 1103-1111.
8. Conquer, J.A.; Tierney, M.C.; Zecevic, J.; Bettger, W.J.; Fisher, R.H.., Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids, 2000, 35(12), 1305-1312.
9. Pomponi, M.F.; Gambassi, G.; Pomponi, M.; Di Gioia, A.; Masullo, C. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease? Ageing Res. Rev., 2011, 10(1), 124-31.
10. Kim, H. Y. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem, 2007, 282, 18661-18665.
11. Pettegrew, J. W.; Panchalingam, K.; Hamilton, R. L.; McClure, R. J. Brain membrane phospholipid alterations in Alzheimer’s disease. Neurochem. Res., 2001, 26, 771-782.
12. Grimm, M.O.; Grösgen, S.; Riemenschneider, M.; Tanila, H.; Grimm, H.S.; Hartmann, T. From brain to food: analysis of phosphatidylcholins, lysophosphatidylcholins and phosphatidylcholinplasmalogens derivates in Alzheimer’s disease human post mortem brains and mice model via mass spectrometry. J. Chromatogr. A., 2011, 1218, 7713-7722.
13. Yuki, D.; Sugiura, Y.; Zaima, N.; Akatsu, H.; Takei, S.; Yao, I.; Maesako, M.; Kinoshita, A.; Yamamoto, T.; Kon, R.; Sugiyama, K. Setou, M. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. Sci. Rep., 2014, 4, 7130.
14. Ohkubo, T.; Tanaka, Y. Administration of DHA-PS to aged mice was suitable for increasing hippocampal PS and DHA ratio. J. Oleo Sci., 2010, 59(5), 247-53.
15. Hiratsuka, S.; Koizumi, K.; Ooba, T.; Yokogoshi, H. Effects of dietary docosahexaenoic acid connecting phospholipids on the learning ability and fatty acid composition of the brain. J. Nutr. Sci. Vitaminol. (Tokyo), 2009, 55(4), 374-80.
16. Hiratsuka, S.; Ishihara, K.; Kitagawa, T.; Wada, S.; Yokogoshi, H. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice. J. Nutr. Sci. Vitaminol. (Tokyo), 2008, 54(6), 501-6.
17. Ding, N.; Xue, Y.; Tang, X.; Sun, Z.M.; Yanagita, T.; Xue, C.H.; Wang, Y.M. Short-term effects of different fish oil formulations on tissue absorption of docosahexaenoic acid in mice fed high- and low-fat diets. J. Oleo Sci., 2013, 62(11), 883-91.
18. Wu, F.J.; Xue, Y.; Liu, X.F.; Xue, C.H.; Wang, J.F.; Du, L.; Takahashi, K.; Wang, Y.M. The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumariafrondosa on oxidative stress in PC12 cells and SAMP8 mice. Neurochem. Int., 2014, 64, 9-17.
19. Wu, F.J.; Xue, Y.; Tang, Q.J.; Xu, J.; Du, L.; Xue, C.H.; Takahashi, K.; Wang, Y.M. Protective effects of cerebrosides from sea cucumber and starfish on the oxidative damage in PC12 cells. J. Oleo Sci., 2013, 62(9), 717-27.
20. Xu, J.; Guo, S.; Du, L.; Wang, Y.M.; Sugawara, T.; Hirata, T.; Xue, C.H. Isolation of cytotoxic glucoerebrosides and long-chain bases from sea cucumber Cucumariafrondosa using high speed counter-current chromatography. J. Oleo Sci., 2013, 62(3), 133-42.
21. Zhao, C.H. Liu, H.Q., Cao, R., Ji, A.L., Zhang, L., Wang, F., Yang, R.H. Effects of dietary fish oil on learning function and apoptosis of hippocampal pyramidal neurons in streptozotocin-diabetic rats. Brain Res., 2012, 1457, 33-43.
22. Gamoh, S.; Hashimoto, M.M.; Yanagimoto, K.; Katakura, M.; Abdul, H.M.; Shido, O. Krill-derived phospholipids rich in n-3 fatty acid improve spatial memory in adult rats. J. Agric. Sci., 2011, 3, 3-12.
23. Hiratsuka, S.; Koizumi, K.; Ooba, T.; Yokogoshi, H. Effects of dietary docosahexaenoic acid connecting phospholipids on learning ability and fatty acid composition of the brain. J. Nutr. Sci. Vitaminol., 2009, 55, 374-380.
24. Lim, S.Y.; Suzuki, H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice. J. Nutr., 2000, 130(6), 1629-32.
25. Lu, J.; Li, T.; He, R.Q.; Bartlett, P.; Götz, J. Visualizing the microtubule- associated protein Tau in the nucleus. Sci. China Life Sci., 2014, 57(4), 422-431.
26. Gasparova, Z.; Stara, V.; Janega, P.; Navarova, J.; Sedlackova, N.; Mach, M.; Ujhazy, E. Pyridoindole antioxidant-induced preservation of rat hippocampal pyramidal cell number linked with reduction of oxidative stress yet without influence on cognitive deterioration in Alzheimer-like neurodegeneration. Neuro Endocrinol. Lett., 2014, 35(6), 454-462.
27. Zhou, H.L.; Mangelsdorf, M.; Liu, J.H.; Zhu, L.; Wu, J.Y. RNAbinding proteins in neurological diseases. Sci. China Life Sci., 2014, 57(4), 432-444.
28. Nguyen, T.H.; Qiu, X.; Sun, J.; Meunier, F.A. Frederic A. Meunier. Bulk endocytosis at neuronal synapses. Sci. China Life Sci., 2014, 57, 378-383.
29. Son, H.; Banasr, M.; Choi, M.; Chae, S.Y.; Licznerski, P.; Lee, B.; Voleti, B.; Li, N.; Lepack, A.; Fournier, N.M.; Lee, K.R.; Lee, I.Y.; Kim, J.; Kim, J.H. Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proc. Natl. Acad. Sci. USA, 2012, 109 (28), 11378-11383.
30. Subash, S.; Essa, M.M.; Al-Asmi, A.; Al-Adawi, S.; Vaishnav, R.; Braidy, N.; Manivasagam, T.; Guillemin, G.J. Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer's disease. J. Tradit. Complement Med., 2014, 4(4), 232-238.
31. Chen, J.Y.; Sun, M.R.; Wang, X.H.; Lu, J.; Wei, Y.;, Tan, Y.; Liu, Y., Götz, J., He, R.Q. The herbal compound geniposide rescues formaldehyde induced apoptosis in N2a neuroblastoma cells. Sci. China Life Sci., 2014, 57(4), 412-421.
32. Taylor, C.J.; He, R.Q.; Barlett, P.F. The role of the N-methy-Daspartate receptor in the proliferation of adult hippocampal neural stem and precursor cells. Sci. China Life Sci., 2014, 57(4), 403-411.